Byline: Will Doss
-
Interaction of Mitochondria and Lysosomes Key in Parkinson’s Disease
Prolonged contact between the mitochondria and the lysosome causes aberrant distribution of mitochondria, contributing to neuronal dysfunction in Parkinson’s disease.
-
Miller Receives Biomaterials Award for Celiac Disease Nanoparticle Therapy
Stephen Miller, PhD, received the 2021 Technology Innovation and Development Award from the Society For Biomaterials for work on a nanoparticle that induces gluten tolerance in celiac disease.
-
Northwestern Faculty Inducted into Prominent Medical Societies
Several Feinberg faculty members have been elected to the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP).
-
Mapping Neural Connections in Parkinson’s Disease
Imbalanced activation of cells and previously unknown neural connections may be responsible for some motor symptoms in Parkinson’s disease and similar neurodegenerative conditions, according to two recent studies.
-
Inhibiting SAM Biosynthesis to Slow Tumor Growth
Inhibiting production of a key material produced by the mTOR pathway could slow tumor growth, according to a recent Northwestern Medicine study.
-
Inflammation Protection May Be Critical to Treating MS
Prolonging a cellular defense response to inflammation could help regenerate the protective coating of axons that is degraded in diseases such as multiple sclerosis, according to a recent study.
-
Antibody Bolsters Immune Response to Glioblastoma
Northwestern Medicine scientists have engineered a novel antibody that revitalizes immune cell activity in a deadly brain cancer, according to a recent study.
-
Next-Gen Sequencing
Northwestern’s investment in next-generation sequencing is leading to unprecedented avenues of discovery.
-
Conformational Switch Implicated in Neurodegenerative Diseases
Northwestern Medicine scientists have discovered a conformational “switch” that determines the function of the SNARE protein Ykt6, with implications for synucleinopathies, according to a recent study.
-
Immune Receptor Linked to Chronic Heart Transplant Rejection
The AXL immune cell receptor has been linked to cardiac allograft vasculopathy, a thickening of vessel walls in transplanted hearts years after implantation, according to a recent study.
